Skip to main content

BlueYard Capital — Portfolio, Page 2

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

67
Companies
$652.8M
Total invested
$12.8M
Avg. check
57
Industries
Biotechnology 8Medical 4Blockchain 3Software 3Health Care 3Electronics 3+51 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 2548 of 67
Agnostic
March 2024

Agnostic is an app development and analytics platform that helps build and analyse blockchain data.

Analytics · Paris$2.2M Seed
Kiln
January 2024

Kiln creates an enterprise-level pledge platform and provides one-click pledge services for encrypted assets.

Blockchain · Paris$17.0M Series A
Tableland
April 2023

TablelandTableland is a permissionless relational database designed for web3 developers.

Cloud Computing · Mill Valley$8.0M Series A
Sensible Biotechnologies
April 2023

Sensible Biotechnologies is developing world's first cell-based platform to unlock the next generation of mRNA medicines.

Biotechnology · Cambridge$4.2M Pre-Seed
VECTARY
January 2023

VECTARY is a design platform that specializes in the fields of augmented reality, computer vision, and 3D technology.

3D Technology · Redwood City$4.6M Venture - Series Unknown
bit.bio
January 2026

Bit.bio provides engineered human cell products and platform services for biomedical research, drug discovery, and cell therapy development.

Biotechnology · Cambridge$50.0M Series C
AnySignal
December 2025

AnySignal is an integrated sensing and communications products company.

Communication Hardware · Gardena$24.0M Series A
Corintis
December 2025

Corintis develops, produces, and tests microfluidic cooling for data center chips.

Electronics · Lausanne$25.0M Corporate Round
ETHGas
December 2025

ETHGas is a marketplace for Ethereum blockspace commitments.

Information Technology · Hong Kong$12.0M Seed
ZeroPhase
December 2025

ZeroPhase creates robust, scalable, software-defined connectivity systems that are independent.

Communications Infrastructure · Unterschleißheim$6.8M Seed
SeeQC
January 2026

SeeQC is a semiconductor company that develops quantum computing systems and offers chip fabrication services to businesses.

Electronics · Elmsford$19.2M Venture - Series Unknown
Clock Bio
October 2024

Clock Bio operates as a biotech company.

Biotechnology · Cambridge$5.3M Seed
Cryptio
March 2026

Cryptio is a fintech and SaaS company that offer accounting, audit and tax software for digital assets.

Accounting · Paris$45.0M Series B
Rapidata
February 2026

Rapidata is a data processing platform that offers human-verified innovative datalabeling and data processing services at scale.

Cloud Data Services · Zürich$8.5M Seed
Aerska
February 2026

Aerska is a biotechnology company that is creating RNA medications to treat, delay, and prevent brain disorders.

Biotechnology · Dublin$39.0M Series A
Biomia
February 2026

Biomia is a synthetic biology company developing plant-derived natural products for unmet medical needs.

Biotechnology · LyngbySeed
Visolis
January 2026

Visolis provides biomanufacturing solutions by combining synthetic biology and chemical catalysis to produce bio-based chemicals and fuels.

Biotechnology · Hayward$2.9M Grant
Manex
June 2025

Manex is revolutionizing process steering and industrial quality management through its manufacturing optimization agents.

Artificial Intelligence (AI) · Munich$9.1M Seed
Grouphug
April 2025

Generates memes from the archive of group WhatsApp chats

Digital Media · Montréal$1.7M Pre-Seed
Recall Labs
March 2025

Recall Labs is building new digital experiences by focusing on user privacy, transparency, and decentralization.

iOS · Sunnyvale$30.0M Series A
Privy
March 2025

Privy provides infrastructure for building on crypto rails, allowing for secure wallet creation and onchain integrations.

Cyber Security · New York$15.0M Series Unknown
Meatable
November 2024

Meatable is a food production company that produces guilt-free meat.

Food and Beverage · LeidenSeries Unknown
CPTx
September 2024

CPTx develops single-stranded DNA products to neutralize viruses and address infectious diseases.

Biotechnology · Planegg$29.0M Series Unknown
ExpressionEdits
May 2024

ExpressionEdits is a biotechnology company that redesigns synthetic DNA instructions using AI, focusing on protein expression.

Artificial Intelligence (AI) · Haverhill$13.0M Seed

Where BlueYard Capital invests

Biotechnology8
Medical4
Blockchain3
Software3
Health Care3
Electronics3

About BlueYard Capital's portfolio

How many companies has BlueYard Capital invested in?

BlueYard Capital has invested in 67 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does BlueYard Capital invest in?

BlueYard Capital's top investment sectors include Biotechnology, Medical, Blockchain, Software, Health Care. The firm invests across 57 different industry categories.

What is BlueYard Capital's largest investment?

Among tracked funding rounds, bit.bio received $50.0M in a Series C round. BlueYard Capital's total known invested capital is $652.8M.

What is the average investment size for BlueYard Capital?

BlueYard Capital's average investment size is $12.8M across its portfolio of 67 companies.

What are BlueYard Capital's most recent investments?

Recent BlueYard Capital portfolio additions include Agnostic, Kiln, Tableland, Sensible Biotechnologies, VECTARY. These companies were founded in 2020 or later.

Reach the founders behind these 67 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →